Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

Steven M. Harris, Esq.  |  Issue: April 2020  |  March 17, 2020

Standard of care & prescribing—The American Medical Association (AMA) recommends a patient-physician relationship be clearly established before the provision of any telemedicine services to a patient, including teleprescribing. However, each state has different requirements.

Knowing when a physician-patient relationship forms is not only important, it is vital to avoid adverse treatment consequences and, ultimately, malpractice actions. Some states require initial face-to-face encounters prior to the commencement of telemedicine services, while other states permit a consultation with another physician who has an ongoing relationship with the same patient.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Regarding teleprescribing, certain states require a physical exam in person prior to authorizing prescribing, while others allow a telehealth exam before prescribing can occur.

Reported cases in which physician-patient relationships were not clearly established have resulted in patient lawsuits against physicians alleging neglect or abandonment. For this reason, many states also require the physician to agree to supervise the patient’s care, rather than merely to engage in isolated transactions.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Informed consent—The ATA recommends obtaining informed patient consent as a best practice, but it is actually required by law in 39 states, and often before a patient can begin a telemedicine treatment program. Some states require a standard form to be signed, but others permit a patient’s oral statement at the beginning of a telemedicine session.

Not only is failure to obtain proper patient consent a potential issue for malpractice, it is a requirement for reimbursement through some states’ Medicaid plans. Georgia is one state with a robust policy on telemedicine informed consent and provides a good example form in its Medicaid Telehealth Manual.

Federal Laws

HIPAA—Under HIPAA, telemedicine providers should permit only authorized users to have access to protected health information (PHI). This means using business associate agreements (BAAs) with medical billing services, information technology (IT) consultants or other vendors of healthcare services, such as pharmacy benefit managers.

Telemedicine providers are expected to use “reasonable and appropriate safeguards” to prevent PHI breaches, including data and cyber security software programs. Telemedicine providers should consider monitoring access through the use of an external IT company, because providers will engage in live or recorded treatment sessions and communication with patients, which could include the transmission of medical records, visual images, live or recorded video of the patient—all potentially subject to hacking through weak internet networks.

Note: On March 17, the U.S. Department of Health & Human Services (HHS) Office for Civil Rights announced it would waive potential penalties for HIPAA violations against any healthcare providers treating patients through remote technology communication during the COVID-19 health emergency. This OCR penalty discretion permits physicians to use widely available applications, such as Skype, Facebook Messenger or Google Hangouts, to assess and treat patients with suspected COVID-19 symptoms or non-COVID-19 medical conditions for convenience and to help limit the spread of possible infections.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:Legal UpdatesProfessional Topics Tagged with:COVID-19telehealthtelemedicine

Related Articles

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    Reimbursement Tips: Telemedicine & Coding in the Time of COVID-19

    April 24, 2020

    Humans may fear change as a general rule, but we’re adaptable when we need to be. In this era of COVID-19 and social distancing, medical practices and payers are adapting to an increased use of telemedicine, which enables providers to see their patients without being in a room with them. To cope, the Centers for…

    The ACR Releases New Telemedicine Position Statement

    July 6, 2020

    The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences